Atlas Trials

Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments

Clinical trial NCT06025045 · UNKNOWN

Trial details

NCT number
NCT06025045
Sponsor
Jing Li
Status
UNKNOWN
Study type
OBSERVATIONAL
Ovarian Cancer Stage IVOvarian Cancer Stage III
Start date
2022-08-01
Primary completion
2025-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.